Drug Use: Clinical Trials

137 trials for Drug Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

93 completed, 22 unknown, 11 recruiting, 4 not yet recruiting. 92 Not applicable, 12 Phase 2, 6 Phase 4, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable92Completed 67, Unknown 10, Recruiting 7, Active not recruiting 3, Not yet recruiting 3, Terminated 1, Withdrawn 1
Phase 212Completed 8, Recruiting 2, Unknown 2
Phase 46Completed 4, Recruiting 1, Unknown 1
Phase 14Completed 3, Unknown 1
Phase 32Completed 2
Early Phase 11Completed 1

Follow Drug Use: new trials by email Literature Review of Drug Use trials Research Report on Drug Use

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Digital PrEP Micro-Intervention for PWUD in Kazakhstan
Dgital micro-intervention - Drug Use, HIV
Not applicableNot yet recruitingYale University402027-01-012026-10-08
Disease Intervention Specialist (DIS) for SUD
Substance Use Disorder (SUD), Opioid Use Disorder
Not yet recruitingOhio State University12002026-12-012026-10-15
Lakota Family Acceptance Project Pilot RCT
Adapted Lakota Family Acceptance Program - LGBTQ, Racial Disparities
Not applicableNot yet recruitingUniversity of Michigan402026-10-102026-10-13
Development of a Multilevel HIV Prevention Intervention for the Emergency Department
mSYNC - HIV, Drug Use
Not applicableNot yet recruitingBrigham and Women's Hospital1002026-09-012026-07-09
Project REACH: A Comprehensive Telehealth Intervention at Syringe Service Programs to Engage People Who Use Drugs
Project REACH - Substance Use, Drug Use
Not applicableRecruitingUniversity of Minnesota1212026-05-062026-05-19
Lakota Family Acceptance Project
Adapted Lakota Family Acceptance Program - LGBTQ, Racial Disparities
Not applicableCompletedUniversity of Michigan212026-01-202026-09-01
Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
Rapid-Start ART (RS-ART) - Hiv, Drug Use
Not applicableRecruitingYale University1352025-11-042026-09-10
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
Peer-educator-based network - HIV Infections, Substance Use Disorders
Not applicableRecruitingJohns Hopkins University3602025-10-282025-11-10
Family Acceptance Project Online (Pilot RCT)
Family Acceptance Project - Online - LGBTQ, Racial Disparities
Phase 2RecruitingUniversity of Michigan1802025-04-242026-02-11
Harm Reduction Services
Integrated Harm Reduction Intervention (IHRI) - Drug Use, Substance Abuse
Not applicableRecruitingNYU Langone Health2002024-11-252026-08-20
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Low dead-space syringes/needles, Hepatitis C Antibody Rapid Diagnostic Test, HIV rapid Diagnostic Test - Drug Use, Hepatitis
RecruitingMédecins du Monde24002024-09-132026-10-09
Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
Upadacitinib - Inflammatory Disease, Drug Side Effect
UnknownUniversidade do Porto1502024-07-012024-07-15
Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
Native PATHS - Alcohol Drinking, Tobacco Use
Not applicableUnknownUniversity of Rhode Island602024-06-172024-06-05
Social Responses to Stigma
Qualitative interview, participant observation - Stigma, Social, Drug Use
UnknownKing's College London2002024-05-012024-03-05
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab - Nanoliposomal Irinotecan, Cadonilimab
Phase 2RecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences302024-04-172024-12-24
Effect of Dexmedetomidine on Oxygenation and Lung Mechanics
GROUP Dexmedetomidine, GROUP B, GROUP C - Drug Use, Dexmedetomidine
Not applicableUnknownCairo University1762024-04-012024-04-10
Organization-level Youth Engagement Approach for Substance Misuse Prevention
Organization-level Youth Engagement prevention strategy - Drug Use, Substance Use
Not applicableCompletedWake Forest University Health Sciences432024-03-142025-10-31
Families With Pride ("Familias Con Orgullo").
Families with Pride ("Familias con Orgullo") - Depression, Drug Use
Not applicableRecruitingUniversity of Miami3062024-03-112026-05-13
A Model for Drug Concentration Prediction of Vancomycin
no intervention - Critical Illness, Infections
UnknownPeking Union Medical College Hospital4012024-03-012024-05-28
E-PAUse: Encouraging Proper Antibiotic Use in Outpatient Setting
comprehensive multi-component interventions - Drug Use
Not applicableActive not recruitingHamad Medical Corporation1000002023-12-012025-04-03

Showing 20 of 137. Sign in to see all of them.

Narrower conditions

Substance-Related Disorders (22)  ·  Alcohol Drinking (20)  ·  Depression (12)  ·  Acquired Immunodeficiency Syndrome (11)  ·  HIV Infections (10)  ·  Hepatitis C (8)  ·  Anxiety Disorders (7)  ·  Sexual Behavior (7)  ·  Alcoholism (6)  ·  Adolescent Behavior (5)  ·  Drug-Related Side Effects and Adverse Reactions (5)  ·  Medication Adherence (5)  ·  Harm Reduction (4)  ·  Opioid-Related Disorders (4)  ·  Behavior, Addictive (3)

Broader conditions

Behavior (52)  ·  Mental Disorders (42)  ·  Chemically-Induced Disorders (38)  ·  Infections (32)  ·  Communicable Diseases (30)  ·  Virus Diseases (27)  ·  Blood-Borne Infections (26)  ·  RNA Virus Infections (25)  ·  Urogenital Diseases (24)  ·  Drinking Behavior (23)  ·  Genital Diseases (22)  ·  Immune System Diseases (19)  ·  Sexually Transmitted Diseases (19)  ·  Lentivirus Infections (18)  ·  Retroviridae Infections (18)

Interventions

Ethanol (2)  ·  Tablets (2)  ·  bictegravir, emtricitabine, tenofovir alafenamide, drug combination (2)  ·  Acyclovir (1)  ·  Amlodipine (1)  ·  Biological Products (1)  ·  Blood Specimen Collection (1)  ·  Bupivacaine (1)  ·  Buprenorphine (1)  ·  Buprenorphine, Naloxone Drug Combination (1)  ·  COVID-19 Testing (1)  ·  Cefixime (1)  ·  Control Groups (1)  ·  Counseling (1)  ·  Crisis Intervention (1)

Sponsors

University of Michigan (6)  ·  Johns Hopkins Bloomberg School of Public Health (5)  ·  University of California, Los Angeles (5)  ·  University of Miami (5)  ·  ANRS, Emerging Infectious Diseases (3)  ·  Boston Medical Center (3)  ·  Hunter College of City University of New York (3)  ·  Johns Hopkins University (3)  ·  Treatment Research Institute (3)  ·  University of Maryland, College Park (3)  ·  Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer (2)  ·  Hasselt University (2)  ·  Medical University of South Carolina (2)  ·  NYU Langone Health (2)  ·  PT. Kimia Farma (Persero) Tbk (2)

Countries

United States (67)  ·  China (8)  ·  France (8)  ·  Indonesia (7)  ·  Canada (4)  ·  Turkey (Türkiye) (4)  ·  United Kingdom (4)  ·  Spain (3)  ·  Sweden (3)  ·  Vietnam (3)  ·  Belgium (2)  ·  Denmark (2)  ·  Egypt (2)  ·  Italy (2)  ·  Kazakhstan (2)

Top investigators

Adam C Brooks, PhD (3)  ·  Frans D Suyatna (3)  ·  Guillermo Prado, PhD (3)  ·  Lillian Gelberg, MD, MSPH (3)  ·  Tyrel J Starks, PhD (3)  ·  Allison Barlow, PhD (2)  ·  Frederick L Altice, MD (2)  ·  Heidi Resnick, Ph.D. (2)  ·  Katie Edwards, PhD (2)  ·  Leslie Leve, PhD (2)  ·  Oluwaseun Falade-Nwulia, MBBS, MPH (2)  ·  Adeel A. Butt, MBBS, MS (1)  ·  Andrea R Thurman, MD (1)

Results publications

PMID 10103341, PMID 10586010, PMID 11402097, PMID 11981287, PMID 12473535, PMID 12973821, PMID 14667981, PMID 15030944, PMID 15234492, PMID 15255031, PMID 15580599, PMID 15957561, PMID 16374442, PMID 16392991, PMID 16816511, PMID 17036033, PMID 17252706, PMID 17295579, PMID 17426085, PMID 18003941, PMID 18081360, PMID 18159224, PMID 18289791, PMID 18334494, PMID 18546285, PMID 19050195, PMID 19170452, PMID 19485598, PMID 19686522, PMID 19806461, PMID 19901006, PMID 20368313, PMID 20836739, PMID 21178824, PMID 21226886, PMID 21496529, PMID 21636639, PMID 21646940, PMID 21784446, PMID 21809002, PMID 2185908, PMID 22183505, PMID 22206744, PMID 22352857, PMID 22424940, PMID 22532328, PMID 22788780, PMID 22795636, PMID 22875659, PMID 23149172

NIH funding

R34MH134937 (2), 2017 (1), F32MH138253 (1), K01DA048201 (1), K23DA036008 (1), K23DA039179 (1), K23DA041901 (1), K23DA060719 (1), K24DA046569 (1), K24MH086814 (1), P30MH062294 (1), P50DA035763 (1), R01AA016102 (1), R01AA028201 (1), R01AA028507 (1)